Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSecond unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
International Journal of Hematology, 08/26/09
Yamauchi T et al. – Gemtuzumab ozogamicin (GO) is an effective molecular–targeted agent for CD33–positive acute myelogenous leukemia (AML) patients who are resistant to conventional chemotherapy. Recent prospective trials have revealed the safety and efficacy of GO as part of conditioning following allogeneic bone marrow or peripheral blood stem cell transplantation (SCT).
Related Articles
A Phase I Study of the Mammalian Target of Rapamycin Inhibitor Sirolimus and MEC Chemotherapy in Relapsed and Refractory Acute Myelogenous Leukemia
Clinical Cancer Research, 10/26/09
Relevance Score: 80%
Perspectives on RUNX genes: An update
American Journal of Medical Genetics, 10/16/09
Relevance Score: 79%
Cefepime and Mortality in Pediatric Acute Myelogenous Leukemia: A Retrospective Cohort Study
The Pediatric Infectious Disease Journal, 10/05/09
Relevance Score: 79%
Expression of Insulin Receptor Isoform A and Insulin-like Growth Factor-1 Receptor in Human Acute Myelogenous Leukemia: Effect of the Dual-Receptor Inhibitor BMS-536924 In vitro
Cancer Research, 10/05/09
Relevance Score: 79%
Acute myelogenous leukemia in a child with HIV infection
European Journal of Pediatrics, 10/06/09
Relevance Score: 78%
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Unpredictability of iv Busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplant for advanced beta thalassemia: Limited toxicity with a dose adjustment policy
Biology of Blood and Marrow Transplantation, 12/09/09
High levels of B-cell activating factor during the peri-transplant period are associated with the reduced incidence of acute graft-versus-host disease following the myeloablative allogeneic stem cell transplantation
Biology of Blood and Marrow Transplantation, 12/09/09
Improved survival with inhibitory Killer Immunoglobulin Receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation
Biology of Blood and Marrow Transplantation, 12/09/09
Today in Leukemia/Lymphoma...keeping you current
Receive free subspecialty "5-minute updates" via email
Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal-type
Blood, 12/09/09
Differential subcellular localization regulates c-Cbl E3 ligase activity upon Notch3 protein in T-cell leukemia
Oncogene, 12/09/09
Allogeneic Hematopoietic Cell Transplant for Prolymphocytic Leukemia
Biology of Blood and Marrow Transplantation, 12/09/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/09/09
Unpredictability of iv Busulfan pharmacokinetics in children undergoing hematopoietic stem cell transplant for advanced beta thalassemia: Limited toxicity with a dose adjustment policy
Biology of Blood and Marrow Transplantation, 12/09/09
High-dose chemotherapy with blood or bone marrow transplants for rhabdomyosarcoma
Biology of Blood and Marrow Transplantation, 12/09/09
Sponsor
Article Search
Sponsor
Sponsor